Following extensive clinical trials, the FDA today announced its approval of Adlyxin (lixisenatide), a once-daily injection for glycemic control. Adlyxin is a hormone that works to normalize blood sugar levels, and could be a treatment option for the well-over 25 million Americans living with Type 2 diabetes.
The MD Magazine editors rounded up the 10 best stories from July – did you read them all?
Researchers caution that Pregabalin, an agent approved by the FDA to treat epilepsy, fibromyalgia, and neuropathic pain, may be associated with an increased risk of major birth defects after first trimester exposure, though results are inconclusive.
Retrospective analysis of ablation outcomes before and after a medical center began using ultrasound to guide vascular access indicates that the technology significantly reduces complications.
University of Texas at Austin researchers appear to have developed a novel technique based on electrochemical collisions to selectively, rapidly, and sensitively detect single viruses in urine.
Researchers have reported that higher serum clusterin levels in children may be linked with atopic dermatitis symptom, potentially providing a candidate molecule to reflect disease’s severity.
A Danish electronic records review found that the need for Eylea or Lucentis injections for wet age-related macular degeneration did not change after cataract surgery. Also, vision improved more when the time from last injection to cataract surgery was shorter than when it was longer.
Analysis revealed that adding mepolizumab resulted in a cost-effectiveness ratio of $385,546 per quality-adjusted life-year, or QALY; the price would need to be discounted by more than 70% to reach $100,000 per QALY, a common threshold at which patients are willing to pay.
Hospital admission allows clinicians to optimize asthma management even when asthma patients have no breathing complaints or abnormal chest exam findings. Although the illness that prompted admission must be treated quickly, asthma care can also be discussed patients.